NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/28/2025
Back to search
Official data from USPTO
LOMECEL-B
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LOMECEL-B
ST13
US500000090295637Class
1, 5, 42
Filing
90295637
Registration
8005125
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
10/28/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/03/2020
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/23/2021
First use in commerce
06/23/2021
Drawing code
4
Owner type
03
Owner location
WILMINGTON, DE, US
Examiner
MARTIN, CHRISTINE C
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LONGEVERON INC.
Longeveron LLC
Representatives
Bryce J. Maynard BUCHANAN INGERSOLL & ROONEY PC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Medicinal signal cells for scientific and research purposes
Class 5
Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; medicinal signal cells for medical and veterinary use; pharmaceutical and veterinary preparations for the treatment of frailty in humans and animals
Class 42
Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research services involving medicinal stem cells
Publications
History of USPTO decisions and trademark events.
52 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/09/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/30/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/30/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/01/2025
GNRT
NON-FINAL ACTION E-MAILED
04/01/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/01/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/01/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/31/2025
IUAF
USE AMENDMENT FILED
11/15/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/15/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/17/2024
EX5G
SOU EXTENSION 5 GRANTED
05/16/2024
EXT5
SOU EXTENSION 5 FILED
05/16/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/17/2023
EX4G
SOU EXTENSION 4 GRANTED
11/15/2023
EXT4
SOU EXTENSION 4 FILED
11/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/17/2023
EX3G
SOU EXTENSION 3 GRANTED
05/15/2023
EXT3
SOU EXTENSION 3 FILED
05/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/18/2022
EX2G
SOU EXTENSION 2 GRANTED
11/16/2022
EXT2
SOU EXTENSION 2 FILED
11/16/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/16/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/13/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/18/2022
EX1G
SOU EXTENSION 1 GRANTED
05/16/2022
EXT1
SOU EXTENSION 1 FILED
05/16/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/16/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/21/2021
PUBO
PUBLISHED FOR OPPOSITION
09/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/17/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2021
ALIE
ASSIGNED TO LIE
08/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/16/2021
GNRT
NON-FINAL ACTION E-MAILED
04/16/2021
CNRT
NON-FINAL ACTION WRITTEN
04/16/2021
DOCK
ASSIGNED TO EXAMINER
04/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/31/2020
NWAP
NEW APPLICATION ENTERED
11/06/2020
Continuous trademark protection
Get notified about every new filing that threatens LOMECEL-B or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.